- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Amyloidosis
Medical specialists from France tagged as investigators in clinical trials studying Amyloidosis
Total 39 results
-
Alexandra FOUBERT, MdSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Sub-Investigator)
Conditions: -
Andra EZARUSeen in:
- Alpes M, Nice, Nice University Hospital
- Alpes Maritimes, Nice, CHU de Nice
- Provence Alpes Cote d'Azur, Nice, University Hospital of Nice
Trials:- NCT05346627 (Sub-Investigator)
- NCT04695340 (Sub-Investigator)
- NCT05453461 (Sub-Investigator)
- NCT06079567 (Sub-Investigator)
-
Antoine HuartSeen in:
- Toulouse, Hopital De Rangueil CHU
- Toulouse, University Hospital of Toulouse
Trials:- NCT04131309 (Principal Investigator)
- NCT03984721 (Sub-Investigator)
Conditions: -
Antoine SOULAGES, MDSeen in:
- Bordeaux, CHU Bordeaux
- Bordeaux, Reference center for neuromuscular diseases
Trials:- NCT03720275 (Sub-Investigator)
- NCT02539329 (Sub-Investigator)
-
Camille BARANI, MDSeen in:
- Lyon, Centre Hospitalier Saint Joseph Saint Luc
Trials:- NCT04890119 (Sub-Investigator)
Conditions: -
Charlotte CASSETSeen in:
- Grenoble Cedex 9, CHU Grenoble Alpes
Trials:- NCT04225754 (Principal Investigator)
Conditions: -
Christophe Cognard, PHDSeen in:
- Toulouse cedex 9, CHU Purpan. Hôpital Pierre-Paul Riquet
Trials:- NCT03464344 (Sub-Investigator)
Conditions: -
Claire Thalamas, MDSeen in:
- Midi-Pyrénées, Toulouse, Hôpital de Psychiatrie
- Occitanie, Toulouse, Toulouse University Hospital
- Toulouse cedex 9, CHU Purpan. Hôpital Pierre-Paul Riquet
- Toulouse, Centre d' Investigation Clinique de Toulouse et Hopitaux de Toulouse ( Purpan)
Trials:- NCT03464344 (Sub-Investigator)
- NCT03314155 (Sub-Investigator)
- NCT01207336 (Sub-Investigator)
- NCT03923569 (Sub-Investigator)
-
David RIBESSeen in:
- Toulouse, University Hospital of Toulouse
Trials:- NCT03984721 (Sub-Investigator)
Conditions: -
Dominique CHAUVEAUSeen in:
- Toulouse, CHU Toulouse
- Toulouse, University Hospital of Toulouse
Trials:- NCT03323476 (Principal Investigator)
- NCT03984721 (Principal Investigator)
-
Erwan Donal, PrSeen in:
- Rennes, CHU Rennes
Trials:- NCT05873868 (Principal Investigator)
Conditions: -
Eve Cariou, MdSeen in:
- Toulouse, CHU Rangueil Toulouse
Trials:- NCT05873868 (Principal Investigator)
Conditions: -
Gilbert Habib, PrSeen in:
- Marseille, APHM Timone
Trials:- NCT05873868 (Principal Investigator)
Conditions: -
Gilles Barone-Rochette, PrSeen in:
- Grenoble, CHU Grenoble Alpes
Trials:- NCT05873868 (Principal Investigator)
Conditions: -
Gwendal Le Masson, PU-PHSeen in:
- Bordeaux, Reference center for neuromuscular diseases
Trials:- NCT03720275 (Sub-Investigator)
Conditions: -
Henri De CLERMONT GALLERANDE, MDSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Sub-Investigator)
Conditions: -
Igor SIBON, MD,PhDSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Sub-Investigator)
Conditions: -
Jacques Izopet, PHDSeen in:
- Toulouse cedex 9, CHU Purpan. Hôpital Pierre-Paul Riquet
Trials:- NCT03464344 (Sub-Investigator)
Conditions: -
Jean-François DARTIGUES, Md, PhDSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Sub-Investigator)
Conditions: -
Jean-Simon ARNOULD, MDSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Sub-Investigator)
Conditions: -
Karim BelhadjSeen in:
- Créteil, Hopitaux Universitaires Henri-Mondor
Trials:- NCT04131309 (Principal Investigator)
Conditions: -
Laurent SAILLERSeen in:
- Toulouse, University Hospital of Toulouse
Trials:- NCT03984721 (Sub-Investigator)
Conditions: -
Michel CAVALLISeen in:
- Provence Alpes Cote d'Azur, Nice, University Hospital of Nice
Trials:- NCT04695340 (Principal Investigator)
Conditions: -
Michèle ALLARD, MD, PhDSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Principal Investigator)
Conditions: -
Olivier Huttin, PrSeen in:
- Nancy, CHU Nancy Institut Louis Mathieu
Trials:- NCT05873868 (Principal Investigator)
Conditions: -
Olivier LAIREZSeen in:
- Toulouse, University Hospital of Toulouse
Trials:- NCT03984721 (Sub-Investigator)
Conditions: -
Paolo ZANOTTI FREGONARA, MDSeen in:
- Bordeaux, CHU de Bordeaux
Trials:- NCT02196116 (Sub-Investigator)
Conditions: -
Pascal CINTASSeen in:
- Toulouse, University Hospital of Toulouse
Trials:- NCT03984721 (Sub-Investigator)
Conditions: -
Patricia Reant, PrSeen in:
- Bordeaux, CHU Bordeaux Haut-Leveque
Trials:- NCT05873868 (Principal Investigator)
Conditions:
Clinical Trials on Amyloidosis
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
Boston UniversityCorino Therapeutics, Inc.CompletedTransthyretin Amyloidosis | Amyloidosis, Leptomeningeal, Transthyretin-RelatedUnited States
-
Chulalongkorn UniversityUnknown
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
Steen Hvitfeldt PoulsenRecruitingTransthyretin Amyloidosis | Transthyretin Cardiac Amyloidosis | Wild-Type Transthyretin-Related (ATTR)AmyloidosisDenmark
-
IRCCS Policlinico S. MatteoRecruiting
-
University Hospital Center of MartiniqueTerminated
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
Kaneka Medical America LLCRecruitingDialysis AmyloidosisUnited States
-
Peking Union Medical College HospitalRecruitingLight Chain (AL) Amyloidosis | Venetoclax | CCND1 TranslocationChina